Immune checkpoint inhibitor-induced encephalitis with dostarlimab in two patients: Case series

Immune checkpoint inhibitors (ICIs) are being used increasingly in the treatment of several cancers and have been associated with neurological complications including immune checkpoint inhibitor-induced encephalitis (ICI-iE). We present two cases of ICI-iE with the novel agent dostarlimab, which to...

Descripción completa

Detalles Bibliográficos
Autores principales: Marzoughi, Sina, Chen, Tychicus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713022/
https://www.ncbi.nlm.nih.gov/pubmed/34993356
http://dx.doi.org/10.1016/j.ensci.2021.100356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713022/
https://www.ncbi.nlm.nih.gov/pubmed/34993356
http://dx.doi.org/10.1016/j.ensci.2021.100356

Ejemplares similares